PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Dexmethylphenidate ×

UPDATED
Regulatorische Updates
11. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA208756 for Dexmethylphenidate Tablets (Rhodes Pharm)
The FDA has approved application ANDA208756 submitted by Rhodes Pharm for oral dexmethylphenidate hydrochloride tablets in 2.5 mg, 5 mg and 10 mg strengths, though the products are listed as discontinued.